Search

everythinglearnresearchcommunity

for

Search:↓

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Alternative treatments show promise for hair growth beyond traditional methods.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

DHT, a testosterone byproduct, causes male pattern baldness.

Genes and hormones cause hair loss, with four genes contributing equally.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.